Report of a case: Retroperitoneal mucinous cystadenocarcinoma with rapid progression

Kamiyama, Hirohiko; Shimazu, Ai; Makino, Yuji; Ichikawa, Ryosuke; Hobo, Takahiro; Arima, Shuei; Nohara, Shigeo; Sugiyama, Yukiko; Okumura, M; Takei, Masahiko; Miura, Hiroyoshi; Namekata, Koji; Tsumura, Hidenori; Okada, Motoi; Takase, Masaru; Matsumoto, Fumio

doi:10.1016/j.ijscr.2015.04.004

Cited by 11 publications

(12 citation statements)

References 18 publications

(26 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In this setting, the most common approach was the rescue surgery (5 patients) [15,17,21,22,30]; 2 women were treated with chemo-radiotherapy instead (table 2) [3,59]. After the progression of the metastatic disease, some authors re-operated their patients [15,21], others administered a hormonal treatment [21,22] like tamoxifen or chemotherapy (table 2) [21,30,59].…”

Section: Resultsmentioning

confidence: 99%

“…Exclusion criteria were articles not written in English, abstract only and those that were not relevant. If the full text was not free or available or missing additional data were needed, the corresponding author was asked to send it; only two answered (Kamiyama et al [3] and Kessler et al [33]) and their additional information were included in this review. The study population was limited to patients with primary retroperitoneal cystadenocarcinoma and people with benignant tumours were excluded.…”

Section: Methodsmentioning

confidence: 99%

“…Primary retroperitoneal cystoadenocarcinoma (PRC) is a rare retroperitoneal primary tumour with only 71 cases reported in literature from 1977 to 2015 [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59]. …”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Primary Retroperitoneal Cystoadenocarcinoma: A Systematic Review

Pellegrino

Sikokis²,

Bersanelli³

et al. 2016

Gynecol Obstet Invest

View full text Add to dashboard Cite

Background/Aims: The aim of this study was to perform a systematic review on primary retroperitoneal cystoadenocarcinoma (PRC), which is an extremely rare disease. Methods: According to PRISMA guidelines, all the literature about PRC from 1977 to 2015 was reviewed. Thirty articles were selected; characteristics of the patients were collected and described; time to recurrence and overall survival (OS) were investigated when available. Results: Thirty seven patients were included of whom 33 were females; the median age at presentation was 43. PRC was more common in postmenopausal women. Surgery was the standard therapy; the role of chemotherapy and/or radiotherapy was uncertain. Thirty percent of the patients relapsed after 58 months from the surgery; the rupture of the cyst occurred in 13% of the cases and it was associated with poor prognosis as well as premenopausal status. At 125 months from the diagnosis, 72% of the patients were alive and the median OS was not reached. Conclusions: The present systematic review about PRC is the first performed until the date of drafting this paper. We described some clinical features of PRC and their possible prognostic value. No conclusive data can be presented due to the small population analyzed and to publication bias.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Primary Retroperitoneal Cystoadenocarcinoma: A Systematic Review

Pellegrino

Sikokis²,

Bersanelli³

et al. 2016

Gynecol Obstet Invest

View full text Add to dashboard Cite

show abstract

“…However, those with PRMC that includes anaplastic carcinoma and sarcoma components tend to have a poor prognosis. PubMed searches using the keywords “primary retroperitoneal mucinous cystadenocarcinoma” revealed a case report of bone metastasis after tumor resection ( 21 ); however, there were no cases of bone invasion at the time of tumor detection. Therefore, this is the first reported case of PRMC with adjacent bone invasion and distant metastases at the time of detection.…”

Section: Discussionmentioning

confidence: 99%

Primary Retroperitoneal Mucinous Cystadenocarcinoma during Long-term Administration of Infliximab for the Treatment of Crohn's Disease

et al. 2023

View full text Add to dashboard Cite

We herein report a rare case of primary retroperitoneal mucinous cystadenocarcinoma (PRMC) in a 60year-old man. The patient, who had been treated with infliximab for Crohn's disease of the colon for 13 years, was referred to our hospital for lower back pain. Contrast-enhanced computed tomography (CT) and magnetic resonance imaging revealed multiple cystic lesions in the right retroperitoneum, the calcification of the cyst, and bone lesions. Bone and CT-assisted biopsies of the retroperitoneal lesions revealed poorly differentiated adenocarcinoma. The patient was diagnosed with PRMC with bone metastases using immunohistochemical staining and positron emission tomography/CT.

show abstract

“…Stereotactic irradiation had no effect and the patient died after another 7 months. 11 Zanoni et al reported stereotactic irradiation of a peripancreatic recurrence. 12 The peripancreatic lesion remained stable, but progression occurred at other sites.…”

Section: Treatmentmentioning

confidence: 99%